Cargando…

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine

Serum carbohydrate antigen 19-9 (CA 19-9) has been identified as a useful tumour marker for diagnosis of exocrine pancreatic carcinoma, but its value for evaluating the response to chemotherapy with gemcitabine is not clear. Tumour regression in pancreatic carcinoma is hard to determine due to massi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziske, C, Schlie, C, Gorschlüter, M, Glasmacher, A, Mey, U, Strehl, J, Sauerbruch, T, Schmidt-Wolf, I G H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394360/ https://www.ncbi.nlm.nih.gov/pubmed/14562009 http://dx.doi.org/10.1038/sj.bjc.6601263

Ejemplares similares

Invasive fungal infections in neutropenic enterocolitis: A systematic analysis of pathogens, incidence, treatment and mortality in adult patients
por: Gorschlüter, Marcus, et al.
Publicado: (2006)

Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?
por: Gogas, H., et al.
Publicado: (1998)

Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma
por: Schwamborn, Katharina, et al.
Publicado: (2011)

Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable Cholangiocarcinoma
por: Trojan, Jörg, et al.
Publicado: (2022)

Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas
por: Braghiroli, Maria Ignez, et al.
Publicado: (2015)

Reversal of Jaundice in Two Patients with Inoperable Cholangiocarcinoma Treated with Cisplatin and Gemcitabine Combination
por: Criel, Maarten, et al.
Publicado: (2012)

Pancreas Cancer Survival in the Gemcitabine Era
por: Wachtel, Mitchell S., et al.
Publicado: (2008)

CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials
por: Maisey, N R, et al.
Publicado: (2005)

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone
por: Wasan, H S, et al.
Publicado: (2009)

Systemic treatment for inoperable pancreatic adenocarcinoma: review and update
por: Chan, Stephen L., et al.
Publicado: (2014)

Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
por: Forika, Gertrud, et al.
Publicado: (2021)

The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas
por: Rogers, S.J., et al.
Publicado: (2021)

Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?
por: Vogl, Ursula M., et al.
Publicado: (2019)

Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study.
por: Prott, F. J., et al.
Publicado: (1997)

Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications.
por: SÃ¸rensen, J. B., et al.
Publicado: (1989)

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma
por: Bengala, C, et al.
Publicado: (2005)

Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma
por: Farley, Alison M., et al.
Publicado: (2019)

Decrease of CA 19–9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer
por: Halm, U, et al.
Publicado: (2000)

Inoperable Cancer
Publicado: (1901)

Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study
por: Xu, Ruihua, et al.
Publicado: (2017)

Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas(†)
por: Ramanathan, R. K., et al.
Publicado: (2016)

Differentially regulated ADAMTS1, 8, 9, and 18 in pancreas adenocarcinoma
por: Kılıç, Murat Özgür, et al.
Publicado: (2017)

Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer
por: Chuong, Michael D., et al.
Publicado: (2022)

Comparison of Platelet Distribution Width and CA19-9 in Resectable Pancreas Cancer
por: Ulutas, Kemal Turker, et al.
Publicado: (2018)

Treatment of an Inoperable Pancreatic Cyst
por: Gupta, S. C. Das
Publicado: (1936)

Depletion of Macrophages Improves Therapeutic Response to Gemcitabine in Murine Pancreas Cancer
por: Buchholz, Soeren M., et al.
Publicado: (2020)

Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
por: Hessmann, E, et al.
Publicado: (2018)

Is Chemoembolisation of Value in Inoperable Primary Hepatocellular Carcinoma
por: Raoul, Jean-Luc
Publicado: (1998)

The diagnostic value of the foetoacinar pancreatic (FAP) protein in cancer of the pancreas; a comparative study with CA19/9.
por: Fujii, Y., et al.
Publicado: (1987)

Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer
por: Nagaraj, Srinivas, et al.
Publicado: (2004)

The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma
por: Sato, Yuki, et al.
Publicado: (2016)

Thyroidectomy in Inoperable Cancer
Publicado: (1909)

Treatment of Inoperable Cancer
Publicado: (1902)

The Treatment of Inoperable Cancer
Publicado: (1902)

Treatment of Inoperable Cancer
Publicado: (1915)

Clinical outcomes of gemcitabine-loaded callispheres drug-eluting beads for patients with advanced and inoperable lung cancer: A case series study
por: Bi, Yonghua, et al.
Publicado: (2022)

Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer
por: Park, Jun Young, et al.
Publicado: (2018)

Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9
por: Kowalchuk, Roman O., et al.
Publicado: (2021)

MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors
por: Gradiz, Rui, et al.
Publicado: (2016)

A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer.
por: Anderson, H., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_f5n64hoihivp27de4v2dh82nql